Newman CC, et al. Clinicals pearls in dermatology 2017. Disease-a-Month. 2017; doi: org/10.1016/j.disamonth.2017.03.003.
Galadari H, et al. Treatment approaches and outcomes associated with the use of abobotulinumtoxinA for the treatment of hyperhidrosis: A systematic review. Journal of the American Academy of Dermatology. 2021; doi: org/10.1016/j.jaad.2020.07.123.
Hyperhidrosis. American Academy of Dermatology Association. https://www.aad.org/public/diseases/a-z/hyperhidrosis-overview. Accessed June 28, 2022.
Glaser DA, et al. Topical glycopoyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials. Journal of the American Academy of Dermatology. 2018; doi:10.1016/j.jaad.2018.07.002.
Kang S, et al., eds. Hyperhidrosis and anhidrosis. In: Fitzpatrick's Dermatology. 9th ed. McGraw Hill; 2019. https://accessmedicine.mhmedical.com. Accessed June 29, 2022.
Smith CC, et al. Primary focal hyperhidrosis. https://www.uptodate.com/content/search. Accessed June 29, 2022.
Gawkrodger DJ, et al. Derivatives of the skin. In: Dermatology: An Illustrated Colour Text. 7th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed June 29, 2022.
Link JL (expert opinion). Mayo Clinic. July 30, 2022.
Ami T. Allscripts EPSi. Mayo Clinic. July 13, 2022.